跳至主要内容
临床试验/IRCT20211012052740N1
IRCT20211012052740N1尚未招募3 期

Comparison of Therapeutic Effects of Metronidazole in Variable Doses in Eradication of Helicobacterpylori in Dyspeptic Patients

Oroumia University of Medical Sciences0 个研究点目标入组 170 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Dyspeptic Patients with Positive Helicobacterpylori Stool Antigen Test
  • Older than 18 Years Old Persons

排除标准

  • No Referring After Taking the Medication
  • Taking Medications for Less than 10 Days
  • Pregnant or Breastfeeding Women
  • Patients with the History of Major Cardiac, Pulmonary, Renal or Hepatic Disease
  • History of Known Side Effects to the Medications of Therapeutic Regimen
  • Taking Antibiotic during the Last Month

研究者

发起方
Oroumia University of Medical Sciences

相似试验